Association of fish oil supplement use with preservation of brain volume and cognitive function - PubMed (original) (raw)
Association of fish oil supplement use with preservation of brain volume and cognitive function
Lori A Daiello et al. Alzheimers Dement. 2015 Feb.
Abstract
Objective: The aim of this study was to investigate whether the use of fish oil supplements (FOSs) is associated with concomitant reduction in cognitive decline and brain atrophy in older adults.
Methods: We conducted a retrospective cohort study to examine the relationship between FOS use during the Alzheimer's Disease Neuroimaging Initiative and indicators of cognitive decline. Older adults (229 cognitively normal individuals, 397 patients with mild cognitive impairment, and 193 patients with Alzheimer's disease) were assessed with neuropsychological tests and brain magnetic resonance imaging every 6 months. Primary outcomes included (1) global cognitive status and (2) cerebral cortex gray matter and hippocampus and ventricular volumes.
Results: FOS use during follow-up was associated with significantly lower mean cognitive subscale of the Alzheimer's Disease Assessment Scale and higher Mini-Mental State Examination scores among those with normal cognition. Associations between FOS use and the outcomes were observed only in APOE ε4-negative participants. FOS use during the study was also associated with less atrophy in one or more brain regions of interest.
Keywords: Alzheimer's disease; Brain atrophy; Cognition; Docosahexaenoic acid; Omega-3.
Copyright © 2015 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
Similar articles
- IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
Kile S, Au W, Parise C, Rose K, Donnel T, Hankins A, Chan M, Ghassemi A. Kile S, et al. J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):106-112. doi: 10.1136/jnnp-2015-311486. Epub 2015 Sep 29. J Neurol Neurosurg Psychiatry. 2017. PMID: 26420886 Clinical Trial. - Predicting the apolipoprotein E ε4 allele carrier status based on gray matter volumes and cognitive function.
Kim HG, Tian Y, Jung SM, Park S, Rhee HY, Ryu CW, Jahng GH. Kim HG, et al. Brain Behav. 2024 Jan;14(1):e3381. doi: 10.1002/brb3.3381. Brain Behav. 2024. PMID: 38376028 Free PMC article. - Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
Portelius E, Zetterberg H, Skillbäck T, Törnqvist U, Andreasson U, Trojanowski JQ, Weiner MW, Shaw LM, Mattsson N, Blennow K; Alzheimer’s Disease Neuroimaging Initiative. Portelius E, et al. Brain. 2015 Nov;138(Pt 11):3373-85. doi: 10.1093/brain/awv267. Epub 2015 Sep 15. Brain. 2015. PMID: 26373605 Free PMC article. - Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
Bilello M, Doshi J, Nabavizadeh SA, Toledo JB, Erus G, Xie SX, Trojanowski JQ, Han X, Davatzikos C. Bilello M, et al. J Alzheimers Dis. 2015;48(4):987-94. doi: 10.3233/JAD-150400. J Alzheimers Dis. 2015. PMID: 26402108 Free PMC article. - Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials.
Kishi T, Matsunaga S, Oya K, Ikuta T, Iwata N. Kishi T, et al. Int J Neuropsychopharmacol. 2015 Jun 19;18(12):pyv070. doi: 10.1093/ijnp/pyv070. Int J Neuropsychopharmacol. 2015. PMID: 26091818 Free PMC article.
Cited by
- Docosahexaenoic acid and adult memory: a systematic review and meta-analysis.
Yurko-Mauro K, Alexander DD, Van Elswyk ME. Yurko-Mauro K, et al. PLoS One. 2015 Mar 18;10(3):e0120391. doi: 10.1371/journal.pone.0120391. eCollection 2015. PLoS One. 2015. PMID: 25786262 Free PMC article. Review. - APOE Alleles and Diet in Brain Aging and Alzheimer's Disease.
Yassine HN, Finch CE. Yassine HN, et al. Front Aging Neurosci. 2020 Jun 10;12:150. doi: 10.3389/fnagi.2020.00150. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32587511 Free PMC article. Review. - Association between a combination of cognitively stimulating leisure activities and long-chain polyunsaturated fatty acid intake on cognitive decline among community-dwelling older Japanese individuals.
Tokuda H, Horikawa C, Nishita Y, Kaneda Y, Obata H, Rogi T, Izumo T, Nakai M, Shimokata H, Otsuka R. Tokuda H, et al. Front Aging Neurosci. 2024 Aug 7;16:1406079. doi: 10.3389/fnagi.2024.1406079. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39170896 Free PMC article. - The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers.
Wei BZ, Li L, Dong CW, Tan CC; Alzheimer’s Disease Neuroimaging Initiative; Xu W. Wei BZ, et al. Am J Clin Nutr. 2023 Jun;117(6):1096-1109. doi: 10.1016/j.ajcnut.2023.04.001. Epub 2023 Apr 5. Am J Clin Nutr. 2023. PMID: 37028557 Free PMC article. - Associations of fish oil supplementation with incident dementia: Evidence from the UK Biobank cohort study.
Huang Y, Deng Y, Zhang P, Lin J, Guo D, Yang L, Liu D, Xu B, Huang C, Zhang H. Huang Y, et al. Front Neurosci. 2022 Sep 7;16:910977. doi: 10.3389/fnins.2022.910977. eCollection 2022. Front Neurosci. 2022. PMID: 36161159 Free PMC article.
References
- van Gelder BM, Tijhuis M, Kalmijn S, Kromhout D. Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study. Am J Clin Nutr. 2007;85:1142–7. - PubMed
- Barberger-Gateau P, Jutand MA, Letenneur L, Larrieu S, Tavernier B, Berr C. Correlates of regular fish consumption in French elderly community dwellers: data from the Three-City study. Eur J Clin Nutr. 2005;59:817–25. - PubMed
- Huang TL, Zandi PP, Tucker KL, Fitzpatrick AL, Kuller LH, Fried LP, et al. Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology. 2005;65:1409–14. - PubMed
- Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol. 2006;63:1545–50. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K01 AG030514/AG/NIA NIH HHS/United States
- R01 NS036524/NS/NINDS NIH HHS/United States
- R01 HL064342/HL/NHLBI NIH HHS/United States
- K08 HS017735/HS/AHRQ HHS/United States
- U01 AG024904/AG/NIA NIH HHS/United States
- R01 CA155381/CA/NCI NIH HHS/United States
- T32 HL076134/HL/NHLBI NIH HHS/United States
- R01 HL084178/HL/NHLBI NIH HHS/United States
- R01 NR011295/NR/NINR NIH HHS/United States
- P30 AG028740/AG/NIA NIH HHS/United States
- U01 CA1503878/CA/NCI NIH HHS/United States
- R01DA020725/DA/NIDA NIH HHS/United States
- R01 HL089311/HL/NHLBI NIH HHS/United States
- R01 DA020725/DA/NIDA NIH HHS/United States
- R01 MH074368/MH/NIMH NIH HHS/United States
- 5T32HL076134/HL/NHLBI NIH HHS/United States
- R01 CA159954/CA/NCI NIH HHS/United States
- R01 HL109116/HL/NHLBI NIH HHS/United States
- R34DA031057-02/DA/NIDA NIH HHS/United States
- R00AA020235/AA/NIAAA NIH HHS/United States
- R01 DA021729/DA/NIDA NIH HHS/United States
- R01 DK099334/DK/NIDDK NIH HHS/United States
- U01 CA150387/CA/NCI NIH HHS/United States
- R01DA021729/DA/NIDA NIH HHS/United States
- P01AA019072/AA/NIAAA NIH HHS/United States
- R01 AT006948/AT/NCCIH NIH HHS/United States
- R18 DK075371/DK/NIDDK NIH HHS/United States
- R34 DA031057/DA/NIDA NIH HHS/United States
- R56 DK075119/DK/NIDDK NIH HHS/United States
- R01AT006948/AT/NCCIH NIH HHS/United States
- R00 AA020235/AA/NIAAA NIH HHS/United States
- R03 CA153942/CA/NCI NIH HHS/United States
- R01NS080655/NS/NINDS NIH HHS/United States
- R01 NS080655/NS/NINDS NIH HHS/United States
- P30 AG010129/AG/NIA NIH HHS/United States
- R01HL109116/HL/NHLBI NIH HHS/United States
- P01 AA019072/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous